Clinical Trial Update: Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer. [Phase 2]

View source ↗

Summary

An update on a Phase 2 neoadjuvant trial evaluating tailored therapy for hormone receptor-positive, HER2-negative luminal breast cancer; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Borstkanker Onderzoek Groep | Conditions: Breast Neoplasms | Phase 2 | Status: ACTIVE_NOT_RECRUITING